Saturday morning Q & A (2017 Conference) (LDN, low dose naltrexone)

LDN in Clinical Practice - Andrew McCall, MB, ChB, DFM (2021 Conference) (LDN, low dose naltrexone)

The Use of LDN for Ophthalmic Conditions - Sebastian Denison, Pharm (2021 Conference) (LDN, low dose naltrexone)

This talk is about how they utilize LDN, their LDN protocol, and their outcomes and expectations. The information presented about humans can apply to animals as well.

Treating Children’s Health in a Special Needs Pediatric Practice - Brian Udell, MD (2021 Conference) (LDN, low dose naltrexone)

Rheumatology - Update 2021 - Edyta Biernat-Kaluza, MD, PhD (2021 Conference) (LDN, low dose naltrexone)

Lyme Disease - Darin Ingels, ND (2021 Conference) (LDN, low dose naltrexone)

Henoch-Schonlein Purpura - Sally Daughtrey, ND (2021 Conference) (LDN, low dose naltrexone)

In her presentation, Dr. Daughtry explains Henoch-Schonlein (HSP), its triggers and complications (such as serious hidden infections often missed initially), and the use of Low Dose Naltrexone in treating HSP. Dr. Daughtry gives an in-depth look into one pediatric case she treated successfully with LDN.

Autoimmunity in Families - Sarah Zielsdorf, MD, MS (2021 Conference) (LDN, low dose naltrexone)

A Non-Invasive First Approach Toward Idiopathic Female Infertility - Sarah Zielsdorf, MD, MS (2021 Conference) (LDN, low dose naltrexone)